How can something that is used by pretty much everybody on the planet still be emerging from the shadows and only just venturing into the mainstream?

Well, it’s complicated and it’s fragmented and it’s very much like the human condition in that respect. The human condition is the biological mag that industry attempts to navigate but, hitherto, it is the human condition that creates the most insurmountable plot points.

The last decade, however, has witnessed a marked uptick in the ability to see health through a different lens – the prism of difference itself.

There is a new vision for life sciences now, and the great poles of that neo panorama are the realisation that people – in all their kaleidoscopic nuances must be part of the journey (I said the ‘j’ word, forgive me).

The second is technology. Okay, some of it is vaguely threatening (in an existential crisis kind of way) but it is also the conduit through which the appreciation and wonder of difference can be fully leveraged.

The next ten years will propel the pharma rocket ship – and everyone aboard it – into an astonishing climate of clinical colour scapes and intrepid treatment possibilities such as we’ve never seen before.

I know this all sounds like intoxicated New Year optimism, and it is, but absolute truth lies in all of it. Our challenge is to reach out and believe.

Go forth, dear reader,

John Pinching
editor

PharmaTimes Media Ltd,
44 Maiden Lane
Covent Garden
London
WC2E 7LN
Tel: +44 (0)20 7240 6999
www.pharmatimes.com Twitter: @PharmaTimes

EDITORIAL
John Pinching / editor
john.pinching@pharmatimes.com

Iona Everson / group managing editor
iona.everson@pharmatimes.com

Karl Equi / executive director
karl.equi@pharmatimes.com  

SALES & MARKETING
Tara Lovegrove / business director
tara.lovegrove@pharmatimes.com

Luci Sargood / business manager
luci.sargood@pharmatimes.com

SUBSCRIPTIONS/REPRINTS
Digital and paper copies available free to qualifying readers: www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK and £100.00 overseas per annum.

Views expressed by the contributors do not necessarily represent those of the publisher, editor or staff.

Material may not be reproduced in any form without the publisher’s written permission. © Copyright 2025 PharmaTimes Magazine. All rights reserved. PharmaTimes Magazine is published by PharmaTimes Media Ltd, which is registered as a limited company in England; No 09019637.